Contrasting effects of activating mutations of GαS and the thyrotropin receptor on proliferation and differentiation of thyroid follicular cells

Oncogene

Volumn 18, Issue 34, 1999, Pages 4798-4807

  Ludgate, M ^a   Gire, V ^a   Crisp, M ^a   Ajjan, R ^b   Weetman, A ^b   Ivan, M ^a   Wynford Thomas, D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cyclic AMP; G protein; Oncogene; Thyroid; TSH receptor

Indexed keywords

CARRIER PROTEIN; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; IODIDE; MUTANT PROTEIN; THYROGLOBULIN; THYROTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT; THYROID FOLLICLE CELL;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; CYCLIC AMP; DNA; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MEMBRANE PROTEINS; MUTATION; ORGAN SPECIFICITY; RATS; RECEPTORS, THYROTROPIN; RETROVIRIDAE; SELECTION (GENETICS); STEM CELLS; SYMPORTERS; THYROGLOBULIN; THYROID GLAND; THYROTROPIN;

ANIMALIA;

EID: 0033607019     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202864     Document Type: Article

References (37)

1. Ajjan R, Watson P, Findlay C, Metcalfe A, Crisp M, Ludgate M and Weetman A. (1998). J. Endocrinol., 158, 351-358.
2. Bond JA, Wyllie FS, Rowson J, Radulescu A and Wynford-Thomas D. (1994). Oncogene, 9, 281-290.
3. Burns JS, Shaw J, Williams ED and Wynford-Thomas D. (1992). Int. J. Oncol., 1, 79-92.
4. Chomczynski P and Sacchi N. (1987). Analyt. Biochem., 162, 156-159.
5. Costagliola S, Many M-C, Stalmans-Falys M, Tonacchera M, Vassart G and Ludgate M. (1994). Endocrinol., 135, 2150-2159.
6. Dai G, Levy O and Carrasco N. (1996). Nature, 379, 458-460.
7. Danos O and Mulligan RC. (1988). Proc. Natl. Acad. Sci. USA, 85, 6460-6464.
8. Dumont JE, Lamy F, Roger P and Maenhaut C. (1992). Phys. Rev., 72, 667 697.
9. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J and Vassart G. (1994). Nature Genet., 7, 396-401.
10. Fournes B, Monier R, Michiels F, Milgrom E, Misrahi M and Feunteun J. (1998). Oncogene, 16, 985-990.
11. Fuhrer D, Holzapfee H, Wonerow P, Scherbaum W and Paschke R. (1997). J. Clin. Endocrinol. Metab., 82, 3885-3891.
12. Ivan M, Ludgate M, Gire V, Bond JA and Wynford-Thomas D. (1997). J. Clin. Endocrinol. Metab., 82, 2702-2709.
13. Kupperman E, Wen W and Meinkoth JL. (1993). Mol. Cell. Biol., 13, 4477-4484.
14. Lalli E and Sassonecorsi P. (1995). Proc. Natl. Acad. Sci. USA, 92, 9633 9637.
15. Michiels F, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury M, Schlumberger M, Merken L and Monier R. (1994). Proc. Natl. Acad. Sci. USA, 91, 10488-10492.
16. Muca C and Vallar L. (1994). Oncogene, 9, 3647-3653.
17. Nemoz G, Sette C, Hess M, Muca C, Vallar L and Conti M. (1995). Mol. Endocrinol., 9, 1279 1287.
18. O'Sullivan C, Barton CM, Staddon SL, Brown CL and Lemoine NR. (1991). Mol. Carcinogen., 4, 345-349.
19. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G. (1993). Nature, 365, 649-651.
20. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P and VanVliet G. (1997). J. Clin. Endocrinol. Metab., 82, 2695-2701.
21. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont JE and Vassart G. (1995). Mol. Endocrinol., 9, 725-733.
22. Paschke R and Ludgate M. (1997). New Engl. J. Med., 337, 1675 1681.
23. Paschke R, Tonacchera M, Van Sande J, Parma J and Vassart G. (1994). J. Clin. Endocrinol. Metab., 79, 1785-1789.
24. Porcellini A, Ruggiano G, Pannain S, Ciullo I, Amabile G, Fenzi G and Avvedimento EV. (1997). Oncogene, 15, 781-789.
25. Rapoport B, Filetti S, Takai N and Seto P. (1982). FEBS Letts, 146, 23 27.
26. Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S and Suarez HG. (1995a). Oncogene, 11, 1907 1911.
27. Russo D, Arturi F, Suarez H, Schlumberger M, DuVillard JA, Crocetti U and Filetti S. (1996). J. Clin. Endocrinol. Metab., 81, 1548 1551.
28. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard J-AD, Caillou B, Monier R, Rapoport B, Filetti S and Suarez HG. (1995b). J. Clin. Endocrinol. Metab., 80, 1347-1351.
29. Said S, Schlumberger M and Suarez HG. (1994). J. Endocrinol. Invest., 17, 371-379.
30. Van Biesen T, Luttrell LM, Hawes BE and Lefkowitz RJ. (1996). Endocrine Rev., 17, 698 709.
31. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J and Vassart G. (1995). J. Clin. Endocrinol. Metab., 80, 2577 2585.
32. Vassart G and Dumont JE. (1992). Endocrine Rev., 13, 596 611.
33. Williams DW, Williams ED and Wynford-Thomas D. (1988). Br. J. Cancer, 57, 535-539.
34. Wynford-Thomas D. (1993). Cancer Surveys, 16, 115 133.
35. Wynford-Thomas D. (1997a). Eur. J. Cancer, 33, 716-726.
36. Wynford-Thomas D. (1997b). Hormone Res., 47, 145 157.
37. Wynford-Thomas D, Stringer BMJ and Williams ED. (1982). Acta Endocrinol., 101, 562 569.